EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 28th, 2021 • Ambrx Biopharma Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledMay 28th, 2021 Company Industry JurisdictionThis Amendment (the “Amendment”) to the Executive Employment Agreement is made as of the date indicated below. This Amendment amends the Executive Employment Agreement, executed September 24, 2020, by and between Ambrx, a Delaware corporation (the “Company”), and Jinchun (AKA “Joy”) YAN, MD, PhD (“Executive”) (the “Executive Agreement”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 3rd, 2021 • Ambrx Biopharma Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledFebruary 3rd, 2021 Company Industry JurisdictionThis Executive Employment Agreement (“Agreement”) is made effective as of 20 March, 2019 (“Effective Date”), by and between Ambrx, Inc., a Delaware corporation (the “Company”), and Simon Allen (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 3rd, 2021 • Ambrx Biopharma Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledFebruary 3rd, 2021 Company Industry JurisdictionThis Executive Employment Agreement (“Agreement”) is made effective as of December 16, 2020 (“Effective Date”), by and between Ambrx, Inc., a Delaware corporation (the “Company”), and GARY YEUNG, MBA, CFA(“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 3rd, 2021 • Ambrx Biopharma Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledFebruary 3rd, 2021 Company Industry Jurisdiction